BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1857229)

  • 1. Bioassay, purification, cloning, and expression of müllerian inhibiting substance.
    MacLaughlin DT; Epstein J; Donahoe PK
    Methods Enzymol; 1991; 198():358-69. PubMed ID: 1857229
    [No Abstract]   [Full Text] [Related]  

  • 2. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.
    Gustafson ML; Lee MM; Scully RE; Moncure AC; Hirakawa T; Goodman A; Muntz HG; Donahoe PK; MacLaughlin DT; Fuller AF
    N Engl J Med; 1992 Feb; 326(7):466-71. PubMed ID: 1732773
    [No Abstract]   [Full Text] [Related]  

  • 3. Müllerian-inhibiting substance: an update.
    Donahoe PK; Budzik GP; Trelstad R; Mudgett-Hunter M; Fuller A; Hutson JM; Ikawa H; Hayashi A; MacLaughlin D
    Recent Prog Horm Res; 1982; 38():279-330. PubMed ID: 6896925
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of mullerian inhibiting substance as an anti-cancer drug.
    Cate RL; Ninfa EG; Pratt DJ; MacLaughlin DT; Donahoe PK
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 1():641-7. PubMed ID: 3472743
    [No Abstract]   [Full Text] [Related]  

  • 5. Cloning and expression of cDNA for anti-müllerian hormone.
    Picard JY; Benarous R; Guerrier D; Josso N; Kahn A
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5464-8. PubMed ID: 2426698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressor.
    Donahoe PK; Cate RL; MacLaughlin DT; Epstein J; Fuller AF; Takahashi M; Coughlin JP; Ninfa EG; Taylor LA
    Recent Prog Horm Res; 1987; 43():431-67. PubMed ID: 3306839
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced purification of Mullerian inhibiting substance by lectin affinity chromatography.
    Budzik GP; Swann DA; Hayashi A; Donahoe PK
    Cell; 1980 Oct; 21(3):909-15. PubMed ID: 6893682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
    Meyers-Wallen VN; Lee MM; Manganaro TF; Kuroda T; Maclaughlin D; Donahoe PK
    Biol Reprod; 1993 Jun; 48(6):1410-8. PubMed ID: 8318594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotypic antibodies to a monoclonal antibody raised against anti-müllerian hormone exhibit anti-müllerian biological activity.
    Lefèvre G; Tran D; Hoebeke J; Josso N
    Mol Cell Endocrinol; 1989 Mar; 62(1):125-33. PubMed ID: 2787251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-müllerian hormone.
    Josso N
    Clin Endocrinol (Oxf); 1986 Sep; 25(3):331-45. PubMed ID: 3539417
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of monoclonal antibodies for affinity purification of bovine mullerian inhibiting substance activity.
    Shima H; Donahoe PK; Budzik GP; Kamagata S; Hudson P; Mudgett-Hunter M
    Hybridoma; 1984; 3(3):201-14. PubMed ID: 6548727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible purification of mullerian inhibiting substance and a model for its mechanism of action.
    Budzik GP; Donahoe PK; Hutson JM
    Prog Clin Biol Res; 1985; 171():207-23. PubMed ID: 2984697
    [No Abstract]   [Full Text] [Related]  

  • 13. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
    Kurian MS; de la Cuesta RS; Waneck GL; MacLaughlin DT; Manganaro TF; Donahoe PK
    Clin Cancer Res; 1995 Mar; 1(3):343-9. PubMed ID: 9815990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity.
    Lorenzo HK; Teixeira J; Pahlavan N; Laurich VM; Donahoe PK; MacLaughlin DT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):89-98. PubMed ID: 11820299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Precocious production of müllerian inhibitor by the fetal rabbit testis].
    Koike S; Jost A
    C R Seances Acad Sci III; 1982 Dec; 295(12):701-5. PubMed ID: 6820303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.
    Hirobe S; He WW; Lee MM; Donahoe PK
    Endocrinology; 1992 Aug; 131(2):854-62. PubMed ID: 1639028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early expression of AMH in chicken embryonic gonads precedes testicular SOX9 expression.
    Oreal E; Pieau C; Mattei MG; Josso N; Picard JY; Carré-Eusèbe D; Magre S
    Dev Dyn; 1998 Aug; 212(4):522-32. PubMed ID: 9707325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-specific fetal lung development and müllerian inhibiting substance.
    Catlin EA; Powell SM; Manganaro TF; Hudson PL; Ragin RC; Epstein J; Donahoe PK
    Am Rev Respir Dis; 1990 Feb; 141(2):466-70. PubMed ID: 2301861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for müllerian inhibiting substance.
    Lee MM; Cate RL; Donahoe PK; Waneck GL
    Endocrinology; 1992 Feb; 130(2):847-53. PubMed ID: 1346380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into mullerian inhibiting substance and its mechanism of action.
    Lane AH; Donahoe PK
    J Endocrinol; 1998 Jul; 158(1):1-6. PubMed ID: 9713320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.